Advertisement

Topics

Allergan Ligand Retinoid Therapeutics Inc Company Profile

20:30 EDT 19th September 2017 | BioPortfolio

Allergan, Inc., with headquarters in Irvine, California, is a technology-driven, global health care company that develops and commercializes specialty pharmaceutical products for the eye care, neuromuscular, skin care and other specialty pharmaceutical products. Allergan markets products in over 100 countries worldwide that deliver value to our customers, satisfy unmet medical needs and improve people's lives.

Allergan has approximately 5,200 employees worldwide and is differentiated from othr specialty pharmaceutical companies through its discovery-to-development research programs and its global marketing and sales capabilities.

Location

2525 Dupont Drive
Irvine
92715
United States of America

Contact

Phone: 714-246-4500
Fax: 714-246-4162


News Articles [1958 Associated News Articles listed on BioPortfolio]

Allergan, Lyndra collaborate on once-weekly AD therapeutics

Allergan PLC and Lyndra Inc. agreed to collaborate on the development of oral, once-weekly formulations of Allergan's existing Alzheimer's disease (AD) therapeutics.

Allergan Takes to the Clinic the First Alzheimer’s Drug from a €3Bn Deal

Allergan’s partner Heptares Therapeutics has dosed the first patient with a GPCR drug to treat major symptoms of Alzheimer’s disease. A year ago, Allergan signed a massive deal of up to ...

Allergan Takes to the Clinic a New Alzheimer’s Drug from a €3Bn Deal

Allergan’s partner Heptares Therapeutics has dosed the first patient with a GPCR drug to treat major symptoms of Alzheimer’s disease. A year ago, Allergan signed a massive deal of up to ...

Retinoid x receptors RXRs Agonists Pipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, Retinoid x receptors RXRs AgonistsPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Retinoid x receptors RXRs...

Ligand Pharma Earns Milestone Payment On FDA Approval Of Baxdela

WASHINGTON (dpa-AFX) - Ligand Pharmaceuticals Inc. (LGND) announced that partner Melinta Therapeutics, a privately held company, announced on Monday that the U.S. FDA has approved Baxdela (delaflo...

Retinoid x receptors Beta RXRs Agonists Pipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, Retinoid x receptors Beta RXRs AgonistsPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Retinoid x receptors...

Ligand Enters Into Commercial License and Supply Agreement with Amgen for Rights to Use ...

Ligand Pharmaceuticals IncorporatedTodd Pettingill, 858-550-7500investors@ligand.com@Ligand_LGNDorLHABruce Voss, 310-691-7100bvoss@lhai.com Read more...

Ligand to Receive $2 Million from WuXi Biologics for Licensing Clinical-Stage anti-PD-1 ...

Ligand Pharmaceuticals IncorporatedTodd Pettingillinvestors@ligand.com(858) 550-7500@Ligand_LGNDorLHABruce Vossbvoss@lhai.com(310) 691-7100 Read more...

Drugs and Medications [133 Associated Drugs and Medications listed on BioPortfolio]

Refresh classic [Allergan, Inc.]

REFRESH Classic

Refresh liquigel [Allergan, Inc.]

REFRESH LIQUIGEL

Refresh celluvisc [Allergan, Inc.]

REFRESH CELLUVISCLubricant Eye Drops

Refresh plus [Allergan, Inc.]

REFRESH PLUSLubricant Eye Drops

Refresh optive sensitive [Allergan, Inc.]

REFRESH OPTIVE™ Sensitive

PubMed Articles [1474 Associated PubMed Articles listed on BioPortfolio]

Synthesis of novel coumarin nucleus-based DPA drug-like molecular entity: In vitro DNA/Cu(II) binding, DNA cleavage and pro-oxidant mechanism for anticancer action.

Despite substantial research on cancer therapeutics, systemic toxicity and drug-resistance limits the clinical application of many drugs like cisplatin. Therefore, new chemotherapeutic strategies agai...

CD22 Ligands on a Natural N-Glycan Scaffold Efficiently Delivers Tox-ins to B-Lymphoma Cells.

CD22 is a sialic acid-binding immunoglobulin-like lectin (Siglec) that is highly expressed on B-cells and B cell lymphomas, and is a validated target for antibody and nanoparticle based therapeutics. ...

RXRα ligand Z-10 induces PML-RARα cleavage and APL cell apoptosis through disrupting PML-RARα/RXRα complex in a cAMP-independent manner.

The major oncogenic driver of acute promyelocytic leukemia (APL) is the fusion protein PML-RARα originated from the chromosomal translocation t(15;17). All-trans retinoic acid (ATRA) and arsenic trio...

Protein-ligand binding affinity determination by the waterLOGSY method: An optimised approach considering ligand rebinding.

WaterLOGSY is a popular ligand-observed NMR technique to screen for protein-ligand interactions, yet when applied to measure dissociation constants (KD) through ligand titration, the results were foun...

Evolution of the ligand-shell morphology during ligand-exchange reaction on gold nanoparticles.

Ligand exchange reactions are used to achieve nanoparticles coated with a mixture of ligand molecules. Currently, nothing is known on the evolution of the morphology of the ligand shell during the rea...

Clinical Trials [309 Associated Clinical Trials listed on BioPortfolio]

Retinoid 9cUAB30 in Preventing Cancer in Healthy Volunteers

This randomized phase I trial studies the side effects and best dose of retinoid 9cUAB30 in preventing cancer in healthy volunteers. The use of retinoid 9cUAB30 may keep cancer from formin...

Retinol in Aged Skin

Topical therapy with retinoids is the only proven medical therapy for aged/photoaged human skin. However, topical therapy with retinoids often result in unwanted cutaneous dermatitis, inc...

Addition of a Topical Steroid to a Topical Retinoid in Acne Patients

A randomized, split-face, placebo-controlled, double-blind, single-center clinical trial comparing topical retinoid on half the face and retinoid plus topical steroid on the other half.

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Safety and Tolerability of Retinoid QLT091001 in Healthy Volunteers

Healthy volunteer subjects will receive retinoid QLT091001 once-daily for 7 days for safety observation.

Companies [1196 Associated Companies listed on BioPortfolio]

Allergan Ligand Retinoid Therapeutics Inc

Allergan, Inc., with headquarters in Irvine, California, is a technology-driven, global health care company that develops and commercializes specialty pharmaceutical products for the eye care, neuromu...

Allergan, Inc.

Allergan, Inc. is a multi-specialty health care company established 60 years ago with a commitment to uncover the best of science and develop and deliver innovative and meaningful...

Ligand Pharmaceuticals

Ligand is an emerging specialty pharmaceutical company that discovers, develops and markets innovative small molecule drugs to address critical, unmet medical needs. Ligand markets four oncology and d...

Allergan Inc.

Allergan is a multi-specialty health care company established more than 60 years ago with a commitment to uncover the best of science and develop and deliver innovative and meanin...

Ligand Pharmaceuticals Incorporated

Ligand discovers and develops new drugs that address critical unmet medical needs of patients for a broad spectrum of diseases including hepatitis, muscle wasting, Alzheimer's, in...

More Information about "Allergan Ligand Retinoid Therapeutics Inc" on BioPortfolio

We have published hundreds of Allergan Ligand Retinoid Therapeutics Inc news stories on BioPortfolio along with dozens of Allergan Ligand Retinoid Therapeutics Inc Clinical Trials and PubMed Articles about Allergan Ligand Retinoid Therapeutics Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Allergan Ligand Retinoid Therapeutics Inc Companies in our database. You can also find out about relevant Allergan Ligand Retinoid Therapeutics Inc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record